IGF1 and acromegaly: Medical treatment of acromegaly with somatostatin analogs (LA-SMSA) and the GH receptor antagonist, pegvisomant (PEGV), has made it possible to achieve normal serum IGF1 concentrations in most patients with acromegaly.